Heparin ranks second among all high-alert
medication errors1
- 33% of medication errors reported to the Institute of Safe Medication Practices (ISMP) can be attributed to packaging and labeling of drug products.2
- Heparin is considered a high-alert medication due to its potential for significant patient harm if errors occur.1
References:
- Rashidee A, et al. Data trends: Patient Safety & Quality Healthcare. July/Aug 2009.
Available at: www.psqh.com/julyaugust-2009/164-data-trends.htmlwww.psqh.com/julyaugust-2009/164-data-trends.html. Accessed July 6, 2011. - Schlesselman LS. 10 Strategies to Reduce Medication Errors. Pharmacy Times Office of Continuing Professional Education, Plainsboro NJ.
ACPE Program I.D. Number: 0290-000-08-009-H05-P. Available at https://secure.pharmacytimes.com/lessons/200809-01.asp.
Click here to see APP's Solutions
APP's Solutions
APP provides label solutions to help ensure patient safety
- Safety features are designed to help clinicians quickly identify the correct drug and administer the proper dose.
- Enhanced heparin labeling is another example of APP’s proactive efforts to
help reduce medication errors at the
patient level.
Click here to return to previous screen
APP Labeling Enhancements
- Vibrant cap and label colors.
- Critical information enlarged.
- Product name, strength, and volume
in more prominent upright text. - New tear-away safety strip on all
0.5 mL to 2 mL vials (Fill Volume).
Safety Benefits
- More accurate product identification
and differentiation. - Easier dosing recognition,
especially in emergency situations. - Helps clinicians identify the right
dose at a glance. - Helps clinicians differentiate from
Heparin Lock Flush product.
® and APP® are registered trademarks of APP Pharmaceuticals, LLC.